A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing prevalence of chronic respiratory conditions 3.2.1.2 Rising healthcare expenditure 3.2.1.3 Technological advancements in drug discovery 3.2.2 Industry pitfalls & challenges 3.2.2.1 Regulatory hurdles and approval challenges 3.2.2.2 Limited healthcare infrastructure in developing countries 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Pipeline analysis 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company matrix analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy dashboard Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Palivizumab 5.3 Ribavirin 5.4 Motavizumab 5.5 Other drug types Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Oral 6.3 Injectable 6.4 Intranasal 6.5 Other route of administrations Chapter 7 Market Estimates and Forecast, By Patient Type, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Adult 7.3 Pediatrics Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospital pharmacies 8.3 Retail pharmacies & drug stores 8.4 Online pharmacies Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 China 9.4.2 Japan 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Argentina 9.5.4 Rest of Latin America 9.6 Middle East and Africa 9.6.1 South Africa 9.6.2 Saudi Arabia 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 AbbVie Inc. 10.2 AstraZeneca PLC 10.3 Bausch Health Companies Inc. 10.4 Gilead Sciences 10.5 GSK plc 10.6 Johnson & Johnson 10.7 Medivir AB 10.8 Merck & Co., Inc 10.9 Pfizer Inc. 10.10 Sanofi
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook